Clinical Trials Directory

Trials / Conditions / COVID-19 Virus Infection

COVID-19 Virus Infection

16 registered clinical trials studyying COVID-19 Virus Infection.

StatusTrialSponsorPhase
WithdrawnLeidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendu
NCT05085574
Leidos Life SciencesPhase 2
CompletedEvaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Cli
NCT05364268
AudibleHealth AI, Inc.—
CompletedEffect of PPE on Children's Fear in Dental Office
NCT05371561
Fayoum UniversityN/A
CompletedCovid-19 Vaccine Response in Heart Transplant Recipients
NCT05268679
Assistance Publique - Hôpitaux de Paris—
CompletedDoes COVİD-19 m-RNA Vaccine Affect Fertility and Over Reserve ?
NCT05489367
Gaziosmanpasa Research and Education Hospital—
CompletedEvaluation of Clinical Performance and Usability of iStatis COVID-19 Ag Rapid Test at POC
NCT05514691
bioLytical LaboratoriesN/A
CompletedLEAP-CT for Treatment of COVID-19 Patients (Master Protocol)
NCT05077332
Leidos Life SciencesPhase 2
TerminatedLeidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVI
NCT05077969
Leidos Life SciencesPhase 2
TerminatedA Phase 2 Study to Evaluate Biomarker Change, Efficacy, Pharmacokinetics, Safety and Tolerability of Telacebec
NCT04847583
Qurient Co., Ltd.Phase 2
TerminatedSafety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
NCT04778059
US Biotest, Inc.Phase 2
UnknownSafeTy and Efficacy of Preventative CoVID Vaccines
NCT05208983
University Health Network, Toronto—
CompletedClinical Study to Evaluate the Effect of Food Supplement in People Infected With Coronavirus
NCT05446961
SENAI CIMATECPhase 2
WithdrawnHigh-Dose Corticosteroid or Tocilizumab for Clinical Worsening of COVID-19
NCT05133635
Marmara UniversityPhase 4
TerminatedRisk Factors for COVID-19 Mortality
NCT04786808
Teodoro Marcianò—
TerminatedClinical Study for the Treatment With Interferon-ß-1a (IFNß-1a) of COVID-19 Patients
NCT04449380
Emanuele BosiPhase 2
CompletedClinical Trial to Evaluate the Efficacy, Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (COVI
NCT04560881
Laboratorio Elea Phoenix S.A.Phase 3